Literature DB >> 12405162

The soluble tumor necrosis factor receptor I is an early predictor of local infective complications after colorectal surgery.

Robert Slotwiński1, Waldemar L Olszewski, Andrzej Chaber, Maciej Slodkowski, Marzanna Zaleska, Ireneusz W Krasnodebski.   

Abstract

The clinical implications of increased cytokine levels after major surgery remain unclear. In this study, systemic concentration of a spectrum of cytokines, including interleukins IL-6, IL-8, IL-10, IL-1ra, and soluble tumor necrosis factor receptor-I (sTNF-RI) was examined in patients with and without postoperative septic complications following colorectal surgery. Although there were no significant changes in IL-1beta, TNF-alpha, and IL-8 serum levels during the observation period, there was a significant rise in IL-6, IL-1ra, and sTNF-RI concentrations in the entire group of patients between postoperative day 1 and 14. There were no differences between the group without and with local complications when IL-6, IL-1ra, and IL-10 were examined. The serum levels of sTNF-RI, IL-1ra, and IL-6 were found to be sensitive indicators of the pro- and anti-inflammatory response to the surgical trauma, but only sTNF-RI turned out to be a sensitive early marker of local septic postoperative complications in patients with colorectal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12405162     DOI: 10.1023/a:1020022006043

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  42 in total

1.  Procalcitonin in early detection of postoperative complications.

Authors:  H B Reith; U Mittelkötter; E S Debus; C Küssner; A Thiede
Journal:  Dig Surg       Date:  1998       Impact factor: 2.588

2.  Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor.

Authors:  C H Hannum; C J Wilcox; W P Arend; F G Joslin; D J Dripps; P L Heimdal; L G Armes; A Sommer; S P Eisenberg; R C Thompson
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

3.  Inflammatory response after laparoscopic and conventional colorectal resections - results of a prospective randomized trial.

Authors:  W Schwenk; C Jacobi; U Mansmann; B Böhm; J M Müller
Journal:  Langenbecks Arch Surg       Date:  2000-01       Impact factor: 3.445

4.  Prospective randomized study of laparoscopic versus open colonic resection for adenocarcinoma.

Authors:  J G Stage; S Schulze; P Møller; H Overgaard; M Andersen; V B Rebsdorf-Pedersen; H J Nielsen
Journal:  Br J Surg       Date:  1997-03       Impact factor: 6.939

Review 5.  Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)

Authors:  R C Bone
Journal:  Ann Intern Med       Date:  1996-10-15       Impact factor: 25.391

6.  Serum tumor necrosis factor-alpha profile in trauma patients.

Authors:  R Rabinovici; R John; K M Esser; J Vernick; G Feuerstein
Journal:  J Trauma       Date:  1993-11

7.  Early induction of IL-1 receptor antagonist (IL-1Ra) in infants and children undergoing surgery.

Authors:  E M O Nualláin; P Puri; D J Reen
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

8.  Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation.

Authors:  H Küster; M Weiss; A E Willeitner; S Detlefsen; I Jeremias; J Zbojan; R Geiger; G Lipowsky; G Simbruner
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

9.  Prospective randomized study of stress and immune response after laparoscopic vs conventional colonic resection.

Authors:  C Kuntz; A Wunsch; F Bay; J Windeler; F Glaser; C Herfarth
Journal:  Surg Endosc       Date:  1998-07       Impact factor: 4.584

Review 10.  Inhibiting the effects of cytokines in human diseases.

Authors:  W P Arend
Journal:  Adv Intern Med       Date:  1995
View more
  7 in total

Review 1.  Prediction and diagnosis of colorectal anastomotic leakage: A systematic review of literature.

Authors:  Freek Daams; Zhouqiao Wu; Max Jef Lahaye; Johannus Jeekel; Johan Frederik Lange
Journal:  World J Gastrointest Surg       Date:  2014-02-27

2.  Glucose intolerance modifies the inflammatory response after intestinal ischemia-reperfusion.

Authors:  Juan C Garcia-Perez; Javier Arias-Diaz; Elena Vara; Jose L Balibrea
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

Review 3.  Integrated approach to colorectal anastomotic leakage: Communication, infection and healing disturbances.

Authors:  Cloë L Sparreboom; Zhou-Qiao Wu; Jia-Fu Ji; Johan F Lange
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

4.  Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.

Authors:  Susanne Herroeder; Sabine Pecher; Marianne E Schönherr; Grit Kaulitz; Klaus Hahnenkamp; Helmut Friess; Bernd W Böttiger; Harry Bauer; Marcel G W Dijkgraaf; Omarcel G W Dijkgraaf; Marcel E Durieux; Markus W Hollmann
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

5.  The diagnostic value of early cytokine response in patients after major trauma - preliminary report.

Authors:  Aneta M Binkowska; Grzegorz Michalak; Sławomir Pilip; Maria Kopacz; Robert Słotwiński
Journal:  Cent Eur J Immunol       Date:  2018-03-30       Impact factor: 2.085

6.  Correlation of TNF-α and TGF-β polymorphisms with protein levels in pancreatic ductal adenocarcinoma and colorectal cancer.

Authors:  Małgorzata Zagozda; Agnieszka K Sarnecka; Zuzanna Staszczak; Magdalena Nowak-Niezgoda; Marek Durlik
Journal:  Contemp Oncol (Pozn)       Date:  2019-12-30

7.  The soluble tumor necrosis factor receptor 1 as a potential early diagnostic and prognostic markers in intensive care unit patients with severe infections.

Authors:  Marta Stelmasiak; MaŁgorzata Mikaszewska-Sokolewicz; Grzegorz NiewiŃski; Barbara-Joanna BaŁan; Robert SŁotwiŃski
Journal:  Cent Eur J Immunol       Date:  2020-07-27       Impact factor: 2.085

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.